SUN PHARMACEUTICAL INDUSTRIES LTD.

SUN PHARMACEUTICAL INDUSTRIES LTD. 

 

 

Sun pharma make speciality pharmaceuticals and active pharmaceutical ingredients. Its  brands are prescribed in chronic therapy areas like cardiology, psychiatry, neurology, gastroenterology, diabetology and respiratory.

 

Sun Pharma have the same drive for growth that marked our early days. Sun Pharma came into existence as a startup with just 5 products in 1993. In the time since, it have crossed several milestones to emerge as a leading pharma company in
India, a rank that it have now been at for more than 5 years. (IMS-ORG Retail Store Audit, March 2006)

 

Sun Pharma have reached leadership in each of the therapy areas that we operate in, and are rated among the leading companies by key customers. Strengthening market share and keeping this customer focus remains a high priority area for the company.

 

In the post 1996 years, it have used a combination of internal growth and acquisitions to drive growth; important mergers were those of the US,
Detroit based Caraco Pharm Labs and that of the plant at Halol which is now UKMHRA and USFDA approved.

 

Under a recent corporate development, the areas related to new molecular entities and drug delivery systems are proposed to be demerged into a separate company

CEO and MD of Sun Pharmaceutical Industries is DILIP SANGHAVI  having 70.9 percent of stake .And he is the 8^th richest Indian entrepreneur.

 

Main competitors 

1. Dr Reddy`S Laboratories Limited
2. Biocon Limited
3. Cipla Limited
4. Nicholas Piramal India Limited
5. Pfizer Limited

---

Possibly related posts: (automatically generated)

• Tel-Aviv Court Rules in Favor of Sun Pharmaceutical; No Special Tender Offe…
• Sun To File Amendment to Tender Offer for Taro Waiving Certain Conditions
• Cellumen and Mitsubishi Tanabe Pharma Corporation Collaborate in Discovery …